BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29192701)

  • 1. Aptamer-mediated selective delivery of a cytotoxic cationic NHC-Au(i) complex to cancer cells.
    Niu W; Teng IT; Chen X; Tan W; Veige AS
    Dalton Trans; 2017 Dec; 47(1):120-126. PubMed ID: 29192701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Heterocyclic Carbene-Gold(I) Complexes Conjugated to a Leukemia-Specific DNA Aptamer for Targeted Drug Delivery.
    Niu W; Chen X; Tan W; Veige AS
    Angew Chem Int Ed Engl; 2016 Jul; 55(31):8889-93. PubMed ID: 27311814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosensitization of breast cancer cells using AS1411 aptamer-conjugated gold nanoparticles.
    Mehrnia SS; Hashemi B; Mowla SJ; Nikkhah M; Arbabi A
    Radiat Oncol; 2021 Feb; 16(1):33. PubMed ID: 33568174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamer-based Targeted Delivery of a G-quadruplex Ligand in Cervical Cancer Cells.
    Carvalho J; Paiva A; Cabral Campello MP; Paulo A; Mergny JL; Salgado GF; Queiroz JA; Cruz C
    Sci Rep; 2019 May; 9(1):7945. PubMed ID: 31138870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of melittin to cancer cells by AS1411 anti-nucleolin aptamer.
    Rajabnejad SH; Mokhtarzadeh A; Abnous K; Taghdisi SM; Ramezani M; Razavi BM
    Drug Dev Ind Pharm; 2018 Jun; 44(6):982-987. PubMed ID: 29325460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of Titanocene-Gold Compounds Based on Highly Active Gold(I)-N-Heterocyclic Carbene Anticancer Agents: Preliminary in vitro Studies in Renal and Prostate Cancer Cell Lines.
    Curado N; Giménez N; Miachin K; Aliaga-Lavrijsen M; Cornejo MA; Jarzecki AA; Contel M
    ChemMedChem; 2019 Jun; 14(11):1086-1095. PubMed ID: 30924298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-heterocyclic carbene gold(I) and silver(I) complexes bearing functional groups for bio-conjugation.
    Garner ME; Niu W; Chen X; Ghiviriga I; Abboud KA; Tan W; Veige AS
    Dalton Trans; 2015 Jan; 44(4):1914-23. PubMed ID: 25490699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.
    Luo YL; Shiao YS; Huang YF
    ACS Nano; 2011 Oct; 5(10):7796-804. PubMed ID: 21942498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-heterocyclic carbenes (NHC) with 1,2,4-oxadiazole-substituents related to natural products: synthesis, structure and potential antitumor activity of some corresponding gold(I) and silver(I) complexes.
    Maftei CV; Fodor E; Jones PG; Freytag M; Franz MH; Kelter G; Fiebig HH; Tamm M; Neda I
    Eur J Med Chem; 2015 Aug; 101():431-41. PubMed ID: 26185007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel theranostic system of AS1411 aptamer-functionalized albumin nanoparticles loaded on iron oxide and gold nanoparticles for doxorubicin delivery.
    Baneshi M; Dadfarnia S; Shabani AMH; Sabbagh SK; Haghgoo S; Bardania H
    Int J Pharm; 2019 Jun; 564():145-152. PubMed ID: 30978484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phthalocyanines for G-quadruplex aptamers binding.
    Lopes-Nunes J; Carvalho J; Figueiredo J; Ramos CIV; Lourenço LMO; Tomé JPC; Neves MGPMS; Mergny JL; Queiroz JA; Salgado GF; Cruz C
    Bioorg Chem; 2020 Jul; 100():103920. PubMed ID: 32413624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells.
    Soundararajan S; Wang L; Sridharan V; Chen W; Courtenay-Luck N; Jones D; Spicer EK; Fernandes DJ
    Mol Pharmacol; 2009 Nov; 76(5):984-91. PubMed ID: 19657047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AS1411 Aptamer-Decorated Biodegradable Polyethylene Glycol-Poly(lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non-Small Cell Lung Cancer In Vitro.
    Alibolandi M; Ramezani M; Abnous K; Hadizadeh F
    J Pharm Sci; 2016 May; 105(5):1741-1750. PubMed ID: 27039356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological activity of ester- and amide-functionalized imidazolium salts and related water-soluble coinage metal N-heterocyclic carbene complexes.
    Pellei M; Gandin V; Marinelli M; Marzano C; Yousufuddin M; Dias HV; Santini C
    Inorg Chem; 2012 Sep; 51(18):9873-82. PubMed ID: 22946642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, structures, and selective toxicity to cancer cells of gold(I) complexes involving N-heterocyclic carbene ligands.
    Boselli L; Ader I; Carraz M; Hemmert C; Cuvillier O; Gornitzka H
    Eur J Med Chem; 2014 Oct; 85():87-94. PubMed ID: 25078312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols.
    Hickey JL; Ruhayel RA; Barnard PJ; Baker MV; Berners-Price SJ; Filipovska A
    J Am Chem Soc; 2008 Sep; 130(38):12570-1. PubMed ID: 18729360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamer-Functionalized and Backbone Redox-Responsive Hyperbranched Polymer for Targeted Drug Delivery in Cancer Therapy.
    Zhuang Y; Deng H; Su Y; He L; Wang R; Tong G; He D; Zhu X
    Biomacromolecules; 2016 Jun; 17(6):2050-62. PubMed ID: 27113017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AS1411 aptamer modified carbon dots via polyethylenimine-assisted strategy for efficient targeted cancer cell imaging.
    Kong T; Zhou R; Zhang Y; Hao L; Cai X; Zhu B
    Cell Prolif; 2020 Jan; 53(1):e12713. PubMed ID: 31691382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AS1411 derivatives as carriers of G-quadruplex ligands for cervical cancer cells.
    Figueiredo J; Lopes-Nunes J; Carvalho J; Antunes F; Ribeiro M; Campello MPC; Paulo A; Paiva A; Salgado GF; Queiroz JA; Mergny JL; Cruz C
    Int J Pharm; 2019 Sep; 568():118511. PubMed ID: 31301466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal-NHC complexes: a survey of anti-cancer properties.
    Teyssot ML; Jarrousse AS; Manin M; Chevry A; Roche S; Norre F; Beaudoin C; Morel L; Boyer D; Mahiou R; Gautier A
    Dalton Trans; 2009 Sep; (35):6894-902. PubMed ID: 20449127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.